Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,060.0
-9.7 (-0.32%)

 

  • STI Straits Times Index
    3,060.0
    -9.7 (-0.32%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,732.3
    -5.7 (-0.33%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,577.9
    123.4 (0.48%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,550.5
    64.0 (2.58%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,532.1
    -126.1 (-0.56%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,847.1
    1.8 (0.03%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,156.3
    8.0 (0.37%)
    Index delayed 20 minutes
  • XAO XAO
    6,042.8
    -7.3 (-0.12%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 524.6M
  • Value: 625.9M
  • Rise: 107
  • Fall: 175
  • Unch: 566

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
YZJ Shipbldg SGD1.190-0.180
Rex Intl0.101-0.002
Asiatic0.007-0.001
Thomson Medical0.081-0.001
Genting Sing0.935-0.015
Vallianz0.006-
ICP Ltd0.009-0.001
SingTel3.160+0.020
Ezion0.067-
Rich Capital0.008-0.001

World Indices

World Indices
Name Last Change
Nasdaq 7,485.1 -157.6
HSI 25,577.9 +123.4
HSCEI 10,233.2 +96.4
Jakarta 5,847.3 +2.1
Nikkei 225 22,532.1 -126.1
SSE Comp 2,550.5 +64.0
Shanghai A 2,671.1 +67.1
Shanghai B 261.8 +6.1
ShenZhen A 1,321.3 +33.3
ShenZhen B 856.6 +13.6
Taiwan W 9,919.3 -34.5
PSE Comp 0.0
KOSPI 2,156.3 +8.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Tianjin ZX USD TIANJIN ZHONG XIN PHARM GROUP
Quotes 10 Minutes Delayed. Updated at 19 Oct 2018 15:52
Last (USD): 0.920 Change: +0.005 High: 0.930 Remarks: -
Change (%): +0.55 Low: 0.905
Open 0.920 Yesterday's Close 0.915
Buy Price 0.920 Sell Price 0.925
Buy Volume ('000) 65.9 Sell Volume ('000) 8.4
Cumulative Volume ('000) 138.0 Cumulative Value 126,993
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 0.09498 Trailing EPS (USD) e 0.10621 NAV (USD) b 0.9081
PE a 9.686 Trailing PE f 8.662 Price / NAV b 1.0131
Dividend (USD) d 0.030680 Cash In Hand (USD) g 0.2348 Issued & Paid-up Shares c 200,000,000
Dividend Yield (%) d 3.335 Price / Cash In Hand g 3.918 Treasury Shares h -
Beta - 75 Daysi 0.848 R-Squared - 75 Days(%)i 8.32 Market Cap (M) 707.363
Beta - 500 Daysi 0.619 R-Squared - 500 Days (%)i 4.36 Free Float (%) 92.4
Piotroski F Score 7 Exchange Code T14 Par Value ( RMB ) 1.00000
Under CPF Investment Scheme (CPFIS) Yes
Sector & Industry Manufacturing - Pharmaceuticals: Other
Category Classification China / Medical & Biotechnology
Index Components FTSE ST All-Share Index / FTSE ST China Index / FTSE ST Fledgling Index / FTSE ST Health Care Index / FTSE ST Small Cap Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 25 Jun 2018.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Tianjin ZX USD SGX 707.363 9.686 8.662 1.0131 3.335
Industry China SGX 592.213 11.228 10.244 0.7041 3.787
Medical & Biotechnology SGX 1,091.775 21.501 19.402 1.3430 1.806
Pharmaceuticals: Other SGX 360.144 13.286 11.465 1.0655 3.010
Index FTSE ST All-Share Index SGX 5,140.984 11.737 13.103 1.1596 3.452
FTSE ST China Index SGX 1,872.442 8.340 7.323 0.7903 3.710
FTSE ST Fledgling Index SGX 89.471 32.994 22.861 0.7174 2.822
FTSE ST Health Care Index SGX 679.610 14.493 14.040 1.9698 2.354
FTSE ST Small Cap Index SGX 653.940 634.818 15.463 0.9856 6.081
Local Peer IX Biopharma SGX 109.258 - - 5.0746 -
Local Peer Star Pharm^ SGX 6.533 - - 0.2190 -
Global Peer PERRIGO COMPANY PLC NYSE 9,886.184 82.660 42.123 1.6764 0.911
Global Peer JAZZ PHARMACEUTICALS PLC NASDAQ 9,423.804 19.317 21.712 3.2838 -
Global Peer FOSUN PHARMA HKEx 67,664.810 18.781 18.752 2.2353 1.696
Global Peer BAUSCH HEALTH COMPANIES INC NYSE 8,593.463 3.575 - 2.4786 -
Global Peer ICON NASDAQ 7,984.043 28.364 27.044 6.4452 -
Global Peer SH PHARMA HKEx 48,486.107 11.944 11.072 1.0951 2.558
Global Peer CATALENT INC NYSE 6,118.981 73.194 73.194 5.6308 -
Global Peer AMARIN CORP ADR EACH REP 1 ORD GBP0.50 NASDAQ 5,903.974 - - -83.0992 -
Global Peer SAGE THERAPEUTICS INC NASDAQ 5,778.403 - - 5.3615 -
Global Peer UNITED THERAPEUTICS CORP NASDAQ 5,481.532 13.117 7.691 2.1366 -
Other Global Peers Kalbe Farma Tbk. (IDX), GW PHARMACEUTICALS ADS EA REPR 12 ORD GBP0.00 (NASDAQ), ENDO INTERNATIONAL PLC (NASDAQ), HORIZON PHARMA PLC (NASDAQ), MADRIGAL PHARMACEUTICALS INC (NASDAQ), ARGENX SE SPON ADR EACH REP 1 ORD SHS (NASDAQ), INTERCEPT PHARMACEUTICALS INC (NASDAQ), LUYE PHARMA (HKEx), AERIE PHARMACEUTICALS INC (NASDAQ), IRONWOOD PHARMACEUTICALS INC (NASDAQ), SSY GROUP (HKEx), SUPERNUS PHARMACEUTICALS INC (NASDAQ), MALLINCKRODT PLC (NYSE), MYOKARDIA INC (NASDAQ), LIVZON PHARMA (HKEx), MEDICINES CO (NASDAQ), PACIRA PHARMACEUTICALS INC (NASDAQ), PRESTIGE CONSUMER HEALTHCARE INC (NYSE), CRONOS GROUP INC (NASDAQ), SIHUAN PHARM (HKEx), HEC PHARM (HKEx), TONG REN TANG (HKEx), ZOGENIX INC (NASDAQ), CHINAGRANDPHARM (HKEx), THERAVANCE BIOPHARMA INC (NASDAQ), INNOVIVA INC (NASDAQ), BLACKMORES LTD (ASX), PORTOLA PHARMACEUTICALS INC (NASDAQ), CORCEPT THERAPEUTICS INC (NASDAQ), Kimia Farma Tbk. (IDX), Indofarma Tbk. (IDX), MEGA (SET), REVANCE THERAPEUTICS INC (NASDAQ), INTERSECT ENT INC (NASDAQ), EAGLE PHARMACEUTICALS INC (NASDAQ), AMPHASTAR PHARMACEUTICALS INC (NASDAQ), CLINUVEL PHARMACEUTICALS LTD (ASX), ANI PHARMACEUTICALS INC (NASDAQ), ASSEMBLY BIOSCIENCES INC (NASDAQ), ANIKA THERAPEUTICS INC (NASDAQ), CONSUN PHARMA (HKEx), COLLEGIUM PHARMACEUTICAL INC (NASDAQ), MEI PHARMA INC (NASDAQ), ARQULE INC (NASDAQ), ADAMAS PHARMACEUTICALS INC (NASDAQ), Tempo Scan Pacific Tbk. (IDX), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), FUDANZHANGJIANG (HKEx), SIGA TECHNOLOGIES INC (NASDAQ), ACLARIS THERAPEUTICS INC (NASDAQ), SYNERGY PHARMACEUTICALS INC DEL (NASDAQ), OSIRIS THERAPEUTICS INC (NASDAQ), CATALYST PHARMACEUTICALS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), ALBIREO PHARMA INC (NASDAQ), SHANDONG XINHUA (HKEx), CELYAD ADS EACH REPR 1 ORD (NASDAQ), FOAMIX PHARMACEUTICALS LTD (NASDAQ), OASMIA PHARMACEUTICAL AB ADR EACH REP 3 ORD SHS (NASDAQ), ACELRX PHARMACEUTICALS INC (NASDAQ), GALMED PHARMACEUTICALS LTD (NASDAQ), MARINUS PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), BIODELIVERY SCIENCES INTERNATIONAL (NASDAQ), MELINTA THERAPEUTICS INC (NASDAQ), CERECOR INC (NASDAQ), ACHAOGEN INC (NASDAQ), ELIXINOL GLOBAL LTD (ASX), DOD (SET), SANAI HEALTH GP (HKEx), INTEC PHARMA LTD (NASDAQ), DURECT CORP (NASDAQ), MEDIWOUND LTD (NASDAQ), OCI INTL (HKEx), VERONA PHARMA SPON ADR EACH REP 8 ORD SHS (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), BIOLINE RX LTD SPON ADR EACH REPR 10 ORD ILS0.01 (NASDAQ), TETRAPHASE PHARMACEUTICALS INC (NASDAQ), ZYNERBA PHARMACEUTICALS INC (NASDAQ), INVION LTD (ASX), NEOS THERAPEUTICS INC (NASDAQ), CTI BIOPHARMA CORP (NASDAQ), AXSOME THERAPEUTICS INC (NASDAQ), YSPSAH (Bursa), GOLDEN THROAT (HKEx), OPTHEA LIMITED (ASX), CUMBERLAND PHARMACEUTICALS INC (NASDAQ), PHARMAXIS (ASX), ORAMED PHARMACEUTICALS INC (NASDAQ), ALTHEA GROUP HOLDINGS LTD (ASX), IMPRIMIS PHARMACEUTICALS INC (NASDAQ), JILIN CHANGLONG (HKEx), TIANDA PHARMA (HKEx), KEMPHARM INC (NASDAQ), EAGLE HEALTH HOLDINGS LTD (ASX), SCYNEXIS INC (NASDAQ), BOTANIX PHARMACEUTICALS LTD (ASX), LANSEN PHARMA (HKEx), COGSTATE (ASX), VIVUS INC (NASDAQ), EVOKE PHARMA INC (NASDAQ), VITA LIFE SCIENCES LIMITED (ASX), PLX PHARMA INC (NASDAQ), ACASTI PHARMA INC (NASDAQ), AGILE THERAPEUTICS (NASDAQ), CYTRX CORP (NASDAQ), AMPIO PHARMACEUTICALS INC (NYSE American), IDT AUSTRALIA LIMITED (ASX), ACRUX (ASX), LIPOCINE INC (NASDAQ), C HEALTH GP (HKEx), PAIN THERAPEUTICS (NASDAQ), EYEGATE PHARMACEUTICALS INC (NASDAQ), ARADIGM CORP (NASDAQ), MY SIZE INC (NASDAQ), REGULUS THERAPEUTICS INC (NASDAQ), ANTISENSE THERAPEUTICS (ASX), BAYTACARE PHARM (HKEx), FLEX PHARMA INC (NASDAQ), CANNPAL ANIMAL THERAPEUTICS LTD (ASX), PERNIX THERAPEUTICS HOLDINGS INC (NASDAQ), RITTER PHARMACEUTICALS INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), SONOMA PHARMACEUTICALS INC (NASDAQ), APRICUS BIOSCIENCES INC (NASDAQ), CONTRAVIR PHARMACEUTICALS INC (NASDAQ), Pyridam Farma Tbk (IDX), PHARMAUST LIMITED (ASX), TONIX PHARMACEUTICALS HLDG CORP (NASDAQ), LONGRUN TEA (HKEx), HUA HAN HEALTH (HKEx), C ANIMAL HEALTH (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days --0.025
-2.65 %
20 Days --0.065
-6.60 %
Medium Term Return 3 Months --0.210
-18.58 %
6 Months --0.040
-4.17 %
1 Year --0.170
-15.60 %
Long Term Return 2 Years -+0.150
+19.48 %
3 Years --0.220
-19.30 %
5 Years --0.100
-9.80 %
Annualised Return Annualised --
-2.04 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.890 - 1.290 Change From 1 Year Low +0.030 % Change From 1 Year Low (%) +3.37
Change From 1 Year High -0.370 % Change From 1 Year High (%) -28.68
2 Years Range 0.755 - 1.290 Change From 2 Years Low +0.165 % Change From 2 Years Low (%) +21.85
Change From 2 Years High -0.370 % Change From 2 Years High (%) -28.68
5 Years Range 0.730 - 1.915 Change From 5 Years Low +0.190 % Change From 5 Years Low (%) +26.03
Change From 5 Years High -0.995 % Change From 5 Years High (%) -51.96
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

In the 1950s, with the China government's policy of merging state-owned pharmaceutical enterprises with the private sector, Tianjin Municipal Chinese Medicinal Materials Corpn (TMCM) merged and reorganised the various factories and stores in Tianjin. In December 1992, TMCM was converted from a state-owned enterprise to a company limited by shares whereby shares were issued to legal persons and its employees. In connection therewith, it was renamed Tianjin Traditional Chinese Medicine Group Co Ltd (TTCM). Following the corporatisation of the Company, the shares issued to the employees were traded at the Tianjin Securities Trading Centre.

In conjunction with the proposed public offering, TTCM adopted its present name. Pursuant to the restructuring, it became the holding company for the Group.

The Group's businesses cover a wide range of products including Chinese patent medicine, Chinese medicinal drinks, Chinese medicinal raw materials, biotechnology medicine, chemical raw material medicine and preparations, and nutritional and health products. It has over 800 medicinal products in over 20 types of formulations. The main products are Suxiao Jiuxin pill (used for treatment of heart disease), Huoxiang Zhengqi Soft capsule (used for treatment of intestines and stomach disease), Gengnian An (used for treatment of menopause symptoms), Zi Long Jin tablet (used for treatment of cancer), Xuefu Zhuyu capsule (used for treatment of diseases relating to heart and head blood vessel), Biqi capsule (used for treatment of rheumatism), Anfulong a-2b Interferon (used for increasing immunity ), Ge Lie Qi Te (used for treatment of diabetes), and Te Zi She Fu (used for diminishing inflammation).

The holding company and ultimate holding company is Tianjin Pharmaceutical Hldgs, a company incorporated in Tianjin, China.

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2017 Dec 2017 Part 1(3.65 MB)
Annual Report 2016 Dec 2016 Part 1(2.98 MB)
Annual Report 2015 Dec 2015 Part 1(2.25 MB)
Annual Report 2014 Dec 2014 Part 1(2.46 MB)
Annual Report 2013 Dec 2013 Part 1(1.87 MB)
Part 2(0.02 MB)
Part 3(0.02 MB)
Annual Report 2012 Dec 2012 Part 1(9.46 MB)
Annual Report 2011 Dec 2011 Part 1(11.18 MB)
Annual Report 2010 Dec 2010 Part 1(5.33 MB)
Annual Report 2009 Dec 2009 Part 1(0.75 MB)
Annual Report 2008 Dec 2008 Part 1(2.38 MB)
Annual Report 2007 Dec 2007 Part 1(1.33 MB)
Annual Report 2006 Dec 2006 Part 1(5.41 MB)
Annual Report 2005 Dec 2005 Part 1(0.68 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
18 Oct 2018 0.920 0.920 0.900 0.915 317,000 0.9100
17 Oct 2018 0.920 0.925 0.915 0.915 125,600 0.9202
16 Oct 2018 0.920 0.920 0.900 0.915 158,900 0.9093
15 Oct 2018 0.930 0.930 0.905 0.910 220,600 0.9188
12 Oct 2018 0.920 0.935 0.910 0.930 313,300 0.9212
11 Oct 2018 0.945 0.945 0.910 0.920 723,700 0.9249
10 Oct 2018 0.940 0.965 0.935 0.965 568,400 0.9527
09 Oct 2018 0.950 0.950 0.930 0.930 77,800 0.9388
08 Oct 2018 0.940 0.955 0.935 0.940 363,700 0.9393
05 Oct 2018 0.945 0.950 0.935 0.940 134,800 0.9436
04 Oct 2018 0.965 0.965 0.935 0.945 395,500 0.9474
03 Oct 2018 0.965 0.975 0.960 0.970 50,500 0.9673
02 Oct 2018 0.970 0.975 0.945 0.960 768,300 0.9591
01 Oct 2018 0.980 0.980 0.965 0.975 105,700 0.9718
28 Sep 2018 0.980 0.980 0.960 0.980 491,900 0.9655
27 Sep 2018 0.990 0.995 0.960 0.975 161,400 0.9795
26 Sep 2018 1.000 1.010 0.990 0.990 125,800 1.0006
25 Sep 2018 0.990 1.010 0.990 1.010 224,400 1.0006
24 Sep 2018 1.010 1.010 0.990 1.000 433,800 0.9996
21 Sep 2018 0.995 1.020 0.985 1.020 753,700 1.0080
20 Sep 2018 1.000 1.000 0.980 0.985 422,000 0.9943
19 Sep 2018 0.940 0.990 0.935 0.980 633,200 0.9636
Summary
Current 2 Weeks
(05 Oct 2018 to 18 Oct 2018)
0.945 0.965 0.900 0.915 3,003,800 -
Previous 2 Weeks
(21 Sep 2018 to 04 Oct 2018)
0.995 1.020 0.900 0.945 3,511,000 -
4 Weeks from
(24 Aug 2018 to 20 Sep 2018)
1.010 1.010 0.900 0.985 12,338,100 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.